Jericho Capital Asset Management L.P. Bio N Tech Se Put Options Transaction History
Jericho Capital Asset Management L.P.
- $3.11 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BNTX
# of Institutions
327Shares Held
39.1MCall Options Held
845KPut Options Held
1.23M-
Baillie Gifford & CO8.28MShares$936 Million0.53% of portfolio
-
Primecap Management CO Pasadena, CA4.79MShares$542 Million0.28% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.38MShares$495 Million1.49% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.93MShares$331 Million1.34% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$214 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27.4B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...